Invenio Imaging News and Activities

Invenio Imaging is owned by Mission BioCapital. Mission BioCapital has a direct presence in 2 countries.

Mission BioCapital has 20 subsidiaries including Alessa Therapeutics, Avvio Medical and Avvio Medical AMEA.

They are in:

• Biotechnology76%
• Healthcare10%
• Other14%

Acquisition, funding and merger involving Mission BioCapital.

• Mission BioCapital has just announced a $134 Million fundraising (posted on September 28 2025).

View the org chart displaying its 8 main executives

Most searched biographies at Invenio Imaging

• Jay Trautman, Chief Executive Officer and President
• John Seamans, Board Member
• Adrian Whitford, Independent Board Director

Popular executive movements at Invenio Imaging

• Adrian Whitford has joined the company as Independent Board Director  (posted on January 30 2026).
• John Seamans has joined the company as Board Member  (posted on January 30 2026).

Create your alert
to follow the executive moves at Invenio Imaging.

Mission BioCapital has 3,493 competitors including UnitedHealth Group (United States (USA)), Kaiser Permanente (United States (USA)) and HCA (United States (USA)).

Popular M&A news in Healthcare

• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Freeman Health System has acquired Northwest Health (posted on June 2 2026).
• Garner Health has just announced a $100 Million fundraising (posted on May 29 2026).

Popular contacts in Healthcare

• Ari Bousbib - Chairman and Chief Executive Officer at IQVIA
• Gregory Adams - Chief Executive Officer and Chairman of the Board at Kaiser Permanente
• Pablo Legorreta - Chairman of the Board, Founder and Chief Executive Officer at Royalty Pharma

Learn more about the Healthcare industry

Press releases by Invenio Imaging

Social media about Invenio Imaging

• Invenio Imaging on Wikipedia, Google News & Yahoo Finance
• Invenio Imaging on LinkedIn, X (Twitter) & YouTube